- $19.33m
- -$3.03m
- 10
- 31
- 21
- 10
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 2.5 | 2.69 | 138 | 27.3 | 45.1 |
Operating Profit | -2.5 | -2.69 | -138 | -27.3 | -45.1 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -2.44 | -16.7 | -130 | -26.1 | -50.3 |
Net Income After Taxes | -2.44 | -16.7 | -130 | -26.1 | -50.3 |
Net Income Before Extraordinary Items | |||||
Net Income | -2.44 | -16.7 | -130 | -26.1 | -50.3 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -2.49 | -33.8 | -184 | -26.1 | -50.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -9.82 | -68.5 | -148 | -10.6 | -15.5 |